We are live on ! Find out more
Axa

Axa Portfolio holdings

AUM $91.9M
1-Year Est. Return 27.41%
This Fund
S&P 500
This Quarter Est. Return
+5.67%
1 Year Est. Return
+27.41%
3 Year Est. Return
+100.68%
5 Year Est. Return
+129.89%
10 Year Est. Return
+554.73%
AUM
$23.2B
AUM Growth
+$1.19B
Cap. Flow
-$399M
Cap. Flow %
-1.72%
Top 10 Hldgs %
11.44%
Holding
1,418
New
187
Increased
581
Reduced
380
Closed
112

Top Buys

Rank Stock Value
1
GM icon
General Motors
GM
+$53.1M
2
EXC icon
Exelon
EXC
+$52.7M
3
ORCL icon
Oracle
ORCL
+$42.5M
4
PH icon
Parker-Hannifin
PH
+$37.9M
5
RYAAY icon
Ryanair
RYAAY
+$37.8M

Top Sells

Rank Stock Value
1
FTI icon
TechnipFMC
FTI
+$67.8M
2
ECL icon
Ecolab
ECL
+$56.9M
3
FFIV icon
F5
FFIV
+$46.6M
4
RTX icon
RTX Corp
RTX
+$44.1M
5
GIS icon
General Mills
GIS
+$36.2M

Sector Composition

Rank Sector Weight
1 Technology 18.12%
2 Healthcare 16.35%
3 Financials 11.92%
4 Industrials 9.74%
5 Consumer Discretionary 9.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GWW icon
1026
W.W. Grainger
GWW
$59.8B
$671K ﹤0.01%
3,736
-10,700
-74% -$1.8M
BPMC
1027
DELISTED
Blueprint Medicines
BPMC
$662K ﹤0.01%
+9,500
New +$508K
BRSS
1028
DELISTED
Global Brass & Copper Hldgs, Inc
BRSS
$652K ﹤0.01%
+19,300
New +$592K
MNTA
1029
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
$649K ﹤0.01%
+35,100
New +$587K
RBCAA icon
1030
Republic Bancorp
RBCAA
$1.9B
$646K ﹤0.01%
16,615
-2,000
-11% -$71.2K
VVX icon
1031
V2X
VVX
$2.36B
$645K ﹤0.01%
20,900
+14,100
+207% +$437K
IRM icon
1032
Iron Mountain
IRM
$33.4B
$644K ﹤0.01%
16,567
-448,818
-96% -$16.8M
CAL icon
1033
Caleres
CAL
$425M
$643K ﹤0.01%
+21,068
New +$570K
RCM
1034
DELISTED
R1 RCM Inc. Common Stock
RCM
$637K ﹤0.01%
171,733
+118,833
+225% +$402K
PRDO icon
1035
Perdoceo Education
PRDO
$2.06B
$635K ﹤0.01%
+61,100
New +$566K
ALG icon
1036
Alamo Group
ALG
$2.06B
$633K ﹤0.01%
5,900
+300
+5% +$28.1K
LRN icon
1037
Stride
LRN
$3.47B
$630K ﹤0.01%
35,300
+20,900
+145% +$371K
PKBK icon
1038
Parke Bancorp
PKBK
$409M
$627K ﹤0.01%
34,156
GOLF icon
1039
Acushnet Holdings
GOLF
$4.85B
$625K ﹤0.01%
+35,200
New +$623K
EWN icon
1040
iShares MSCI Netherlands ETF
EWN
$636M
$624K ﹤0.01%
19,893
-8,400
-30% -$256K
IMGN
1041
DELISTED
Immunogen Inc
IMGN
$621K ﹤0.01%
81,200
-226,600
-74% -$1.51M
AAXJ icon
1042
iShares MSCI All Country Asia ex Japan ETF
AAXJ
$3.87B
$617K ﹤0.01%
8,540
+4,630
+118% +$329K
NLY icon
1043
Annaly Capital Management
NLY
$16.1B
$614K ﹤0.01%
12,590
+170
+1% +$8.32K
MKL icon
1044
Markel Group
MKL
$22.2B
$610K ﹤0.01%
571
+14
+3% +$14.5K
CNR
1045
DELISTED
Cornerstone Building Brands, Inc.
CNR
$610K ﹤0.01%
39,100
+22,500
+136% +$372K
ETR icon
1046
Entergy
ETR
$49.2B
$608K ﹤0.01%
15,926
+2,126
+15% +$82.3K
SAFM
1047
DELISTED
Sanderson Farms Inc
SAFM
$608K ﹤0.01%
3,765
OLED icon
1048
Universal Display
OLED
$3.58B
$593K ﹤0.01%
+4,600
New +$557K
EIDO icon
1049
iShares MSCI Indonesia ETF
EIDO
$498M
$590K ﹤0.01%
22,100
+6,500
+42% +$175K
VNO icon
1050
Vornado Realty Trust
VNO
$6.45B
$590K ﹤0.01%
7,680
-1,097
-12% -$83.7K

Similar funds

Axa's Q3 2017 Portfolio in Review

As of Q3 2017, Axa held 1,418 positions worth $23.2B, up 5.4% from $22B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Axa's Q3 2017 filing shows 187 new, 581 increased, 380 reduced and 112 closed positions. Its largest new stake was Ryanair: 836,448 shares worth $35.3M. The largest sale was TechnipFMC, an estimated $67.8M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.

  • Axa's largest Q3 2017 buy was Ryanair: 836,448 shares worth $35.3M.
  • Axa added most to General Motors in Q3 2017, an estimated $53.1M increase.
  • Axa's biggest Q3 2017 reduction was TechnipFMC, cutting an estimated $67.8M.
  • Axa fully exited F5 in Q3 2017, selling an estimated $46.6M.
  • Axa's ten largest holdings make up 11% of its $23.2B portfolio in Q3 2017.
  • Axa opened 187 new positions and closed 112 in Q3 2017.
  • Axa's portfolio value rose 5.4% quarter-over-quarter to $23.2B.

Based on Axa's 13F filing for Q3 2017, filed 13 Nov 2017.